Literature DB >> 24781671

Formulation development and evaluation of innovative two-polymer (SR-2P) bioadhesive vaginal gel.

Satheesh Podaralla1, Carsten Alt, Gita N Shankar.   

Abstract

The main objective of this investigation was to study the feasibility of developing a vaginal bioadhesive microbicide using a SRI's proprietary two-polymer gel platform (SR-2P). Several formulations were prepared with different combinations of temperature-sensitive polymer (Pluronic® F-127) and mucoadhesive polymer (Noveon® AA-1), producing gels of different characteristics. Prototype polymeric gels were evaluated for pH, osmolality, buffering capacity, and viscosity under simulated vaginal semen dilutions, and bioadhesivity using ex vivo mini pig vaginal tissues and texture analyzer. The pH of the polymeric gel formulations ranged from 5.1 to 6.4; the osmolality varied from 13 to 173 mOsm. Absolute viscosity ranged from 513 to 3,780 cPs, and was significantly reduced (1.5- to 3-fold) upon incubation with simulated vaginal and semen fluid mixture. Among the tested gels (indicated in the middle row as a molar ratio of a mixture of Noveon vs. Pluronic), only SR-2P retained gel structure upon dilution with simulated fluids and mild simulated coital stress. The pH of the SR-2P gel was maintained at about 4.6 in simulated vaginal fluid and also showed high peak force of adhesion in mini pig vaginal tissue. Furthermore, SR-2P gel caused no or only minimal irritation in a mouse vaginal irritation model. The results of this preliminary study demonstrated the potential application of SR-2P gel as a vaginal microbicide vehicle for delivery of anti-HIV agents.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24781671      PMCID: PMC4113630          DOI: 10.1208/s12249-014-0124-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  28 in total

1.  Rheological properties of contraceptive gels.

Authors:  D H Owen; J J Peters; D F Katz
Journal:  Contraception       Date:  2000-12       Impact factor: 3.375

2.  Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM).

Authors:  S Garg; R A Anderson; C J Chany; D P Waller; X H Diao; K Vermani; L J Zaneveld
Journal:  Contraception       Date:  2001-07       Impact factor: 3.375

3.  Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions.

Authors:  Jung Yun Chang; Yu Kyoung Oh; Han-gon Choi; Yang Bae Kim; Chong-Kook Kim
Journal:  Int J Pharm       Date:  2002-07-08       Impact factor: 5.875

Review 4.  Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update.

Authors:  Sheryl L Lard-Whiteford; Dorota Matecka; Julian J O'Rear; Ita S Yuen; Charles Litterst; Patricia Reichelderfer
Journal:  J Acquir Immune Defic Syndr       Date:  2004-05-01       Impact factor: 3.731

Review 5.  Qualitative and quantitative intravaginal targeting: key to anti-HIV-1 microbicide delivery from test tube to in vivo success.

Authors:  Viness Pillay; Felix Mashingaidze; Yahya E Choonara; Lisa C Du Toit; Eckhart Buchmann; Vinesh Maharaj; Valence M K Ndesendo; Pradeep Kumar
Journal:  J Pharm Sci       Date:  2012-03-13       Impact factor: 3.534

6.  Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys.

Authors:  P Eckstein; M C Jackson; N Millman; A J Sobrero
Journal:  J Reprod Fertil       Date:  1969-10

7.  Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group.

Authors:  L Van Damme; V Chandeying; G Ramjee; H Rees; P Sirivongrangson; M Laga; J Perriëns
Journal:  AIDS       Date:  2000-01-07       Impact factor: 4.177

8.  Safety and tolerability of the new contraceptive sponge Protectaid.

Authors:  G Creatsas; A Elsheikh; P Colin
Journal:  Eur J Contracept Reprod Health Care       Date:  2002-06       Impact factor: 1.848

Review 9.  Epidemiology of herpes simplex virus type 2 infection in the developing world.

Authors:  Helen Weiss
Journal:  Herpes       Date:  2004-04

10.  The normal microflora of the female rabbit's genital tract.

Authors:  M Jacques; M E Olson; A M Crichlow; A D Osborne; J W Costerton
Journal:  Can J Vet Res       Date:  1986-04       Impact factor: 1.310

View more
  6 in total

1.  SR-2P vaginal microbicide gel provides protection against herpes simplex virus 2 when administered as a combined prophylactic and postexposure therapeutic.

Authors:  Scott A Fields; Gaurav Bhatia; Julie M Fong; Mingtao Liu; Gita N Shankar
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

2.  Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.

Authors:  Gita N Shankar; Carsten Alt
Journal:  J Antimicrob Chemother       Date:  2014-08-19       Impact factor: 5.790

3.  [Acute and chronic toxicity of 0.5% podophyllotoxin-loaded nanostructured lipid carriers to vaginal mucosa in rabbits and rats].

Authors:  Lishi Liu; Kai Han; Qi Wang; Yan Gao; Jingying Wang; Kang Zeng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-12-30

4.  Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation.

Authors:  María-Pilar Sánchez-Sánchez; Araceli Martín-Illana; Roberto Ruiz-Caro; Paulina Bermejo; María-José Abad; Rubén Carro; Luis-Miguel Bedoya; Aitana Tamayo; Juan Rubio; Anxo Fernández-Ferreiro; Francisco Otero-Espinar; María-Dolores Veiga
Journal:  Mar Drugs       Date:  2015-09-18       Impact factor: 5.118

5.  A Cationic Amphipathic Tilapia Piscidin 4 Peptide-Based Antimicrobial Formulation Promotes Eradication of Bacterial Vaginosis-Associated Bacterial Biofilms.

Authors:  Wen-Chun Lin; Yun-Ru Chen; Chi-Mu Chuang; Jyh-Yih Chen
Journal:  Front Microbiol       Date:  2022-03-23       Impact factor: 6.064

Review 6.  Recent Advances in Polymer-Based Vaginal Drug Delivery Systems.

Authors:  Tomasz Osmałek; Anna Froelich; Barbara Jadach; Adam Tatarek; Piotr Gadziński; Aleksandra Falana; Kinga Gralińska; Michał Ekert; Vinam Puri; Joanna Wrotyńska-Barczyńska; Bozena Michniak-Kohn
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.